Atherothrombosis‐on‐Chip: A Site‐Specific Microfluidic Model for Thrombus Formation and Drug Discovery

Abstract

Atherothrombosis, an atherosclerotic plaque disruption condition with superimposed thrombosis, is the underlying cause of cardiovascular episodes. Herein, a unique design is presented to develop a microfluidic site‐specific atherothrombosis‐on‐chip model, providing a universal platform for studying the crosstalk between blood cells and plaque components. The device consists of two interconnected microchannels, namely main and supporting channels: the former mimics the vessel geometry with different stenosis, and the latter introduces plaque components to the circulation simultaneously. The unique design allows the site‐specific introduction of plaque components in stenosed channels ranging from 0% to above 50%, resulting in thrombosis, which has not been achieved previously. The device successfully explains the correlation between vessel geometry and thrombus formation phenomenon as well as the influence of shear rate on platelet aggregation, confirming the reliability and the effectiveness of the design. The device exhibits significant sensitivity to aspirin. In therapeutic doses (50 × 10−6 and 100 × 10−6 m), aspirin delays and prevents platelet adhesion, thereby reducing the thrombus area in a dose‐dependent manner. Finally, the device is effectively employed in testing the targeted binding of the RGD (arginyl‐glycyl‐aspartic acid) labeled polymeric nanoparticles on the thrombus, extending the use of the device to examine targeted drug carriers.

Microfluidic Gut-on-a-Chip: Fundamentals and Challenges

“…Moreover, biological materials, such as collagen can also be used. To increase the biocompatibility of some materials, membranes and microchannels are coated with natural polymers such as extracellular matrix (ECM) proteins such as collagen, fibronectin and gelatin, as they provide natural moiety for cell adhesion and survival [12,[42][43][44]. Although PDMS is the commonly used material, it is unfavourable to cell adhesion, and to address this issue, channels are coated with hydrogel.…”

Advances in haemostatic sponges: Characteristics and the underlying mechanisms for rapid haemostasis

“…Gelatin, a water-soluble protein made from animal collagen, is widely utilised as a biomaterial in food processing, cosmetics, organ-on-chip, and medicine due to its biocompatibility, biodegradability, and biosafety [ [91] , [92] , [93] , [94] ]. When applied to a wound, gelatin promotes clotting by increasing platelet adhesion, aggregation and activation as well as thrombin generation, protein crosslinking, and haemostasis.…”

A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis

“…An in-house polydimethylsiloxane (PDMS) multichannel microfluidic device was used to check the binding affinity of the nanoparticles under flow (see method in Supporting Information). [57]…”